| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1050501519 |
| P356 | DOI | 10.1007/S13277-014-2779-Y |
| P698 | PubMed publication ID | 25371074 |
| P2093 | author name string | Xiaohu Gu | |
| Xiaojing Xing | |||
| Tianfei Ma | |||
| Huinan Ye | |||
| P2860 | cites work | VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling | Q22009049 |
| Angiogenesis in cancer and other diseases | Q27861015 | ||
| Cancer metastasis: building a framework | Q29616783 | ||
| Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis | Q29620559 | ||
| Regulation, regulatory activities, and function of biglycan. | Q30350020 | ||
| Identification of novel candidate tumour marker genes for intrahepatic cholangiocarcinoma | Q33336011 | ||
| Quantitative proteomics analysis integrated with microarray data reveals that extracellular matrix proteins, catenins, and p53 binding protein 1 are important for chemotherapy response in ovarian cancers. | Q33440799 | ||
| Biglycan enhances gastric cancer invasion by activating FAK signaling pathway | Q33688404 | ||
| Glioblastoma stem-like cells give rise to tumour endothelium. | Q34151507 | ||
| Flavonoid, silibinin, inhibits proliferation and promotes cell-cycle arrest of human colon cancer | Q34704147 | ||
| Hematopoietic stem cell antigen CD34: role in adhesion or homing. | Q36538490 | ||
| The angiogenic switch in carcinogenesis | Q37501499 | ||
| VEGF and angiopoietin signaling in tumor angiogenesis and metastasis | Q37863809 | ||
| Biglycan modulates angiogenesis and bone formation during fracture healing | Q38310133 | ||
| Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer | Q38480006 | ||
| Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells | Q39388535 | ||
| Biglycan is overexpressed in pancreatic cancer and induces G1-arrest in pancreatic cancer cell lines | Q40783622 | ||
| Inhibition of tumor growth by targeting tumor endothelium using a soluble vascular endothelial growth factor receptor | Q41070635 | ||
| Matrix protein biglycan induces osteoblast differentiation through extracellular signal-regulated kinase and Smad pathways | Q42818623 | ||
| Biglycan expression and clinical outcome in patients with pancreatic adenocarcinoma | Q43850811 | ||
| Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer. | Q44285244 | ||
| Expression and significance of biglycan in endometrial cancer | Q45391946 | ||
| Prognostic impact of angiogenesis in nonmuscle invasive bladder cancer as defined by microvessel density after immunohistochemical staining for CD34. | Q46304963 | ||
| Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. | Q53089518 | ||
| Biglycan expression correlates with aggressiveness and poor prognosis of gastric cancer. | Q54343967 | ||
| ERK-MAPK signaling opposes Rho-kinase to promote endothelial cell survival and sprouting during angiogenesis | Q58001185 | ||
| Vascular Endothelial Growth Factor Induction of the Angiogenic Phenotype Requires Ras Activation | Q58450934 | ||
| Switch to the angiogenic phenotype during tumorigenesis | Q67715859 | ||
| Up-regulated biglycan expression correlates with the malignancy in human colorectal cancers | Q84860532 | ||
| Thymol inhibits LPS-stimulated inflammatory response via down-regulation of NF-κB and MAPK signaling pathways in mouse mammary epithelial cells | Q85968887 | ||
| P433 | issue | 3 | |
| P921 | main subject | endothelium | Q111140 |
| P1104 | number of pages | 8 | |
| P304 | page(s) | 1773-1780 | |
| P577 | publication date | 2014-11-05 | |
| P1433 | published in | Tumor Biology | Q15757842 |
| P1476 | title | Biglycan up-regulated vascular endothelial growth factor (VEGF) expression and promoted angiogenesis in colon cancer | |
| P478 | volume | 36 |
| Q90480397 | Biglycan as a potential diagnostic and prognostic biomarker in multiple human cancers |
| Q53682357 | Biglycan promotes the chemotherapy resistance of colon cancer by activating NF-κB signal transduction. |
| Q41827719 | Biglycan stimulates VEGF expression in endothelial cells by activating the TLR signaling pathway |
| Q52597557 | Biglycan-mediated upregulation of MHC class I expression in HER-2/neu-transformed cells. |
| Q58613950 | Chronic Obstructive Pulmonary Disease and Lung Cancer: Underlying Pathophysiology and New Therapeutic Modalities |
| Q38394291 | Contribution of Human Fibroblasts and Endothelial Cells to the Hallmarks of Inflammation as Determined by Proteome Profiling |
| Q40294268 | Downregulation of VEGFA inhibits proliferation, promotes apoptosis, and suppresses migration and invasion of renal clear cell carcinoma |
| Q28072886 | Extracellular Matrix, a Hard Player in Angiogenesis |
| Q90181969 | Extracellular Vesicles From Notch Activated Cardiac Mesenchymal Stem Cells Promote Myocyte Proliferation and Neovasculogenesis |
| Q48219599 | Human Metaplastic Breast Carcinoma and Decorin |
| Q28085548 | Insights into the key roles of proteoglycans in breast cancer biology and translational medicine |
| Q92604429 | Prognostic value and association with epithelial-mesenchymal transition and molecular subtypes of the proteoglycan biglycan in advanced bladder cancer |
| Q39012517 | Proteoglycan neofunctions: regulation of inflammation and autophagy in cancer biology. |
| Q92651093 | Quantitative Proteomic Analysis and Evaluation of the Potential Prognostic Biomarkers in Cholangiocarcinoma |
| Q93140491 | SIRT6 regulates the proliferation and apoptosis of hepatocellular carcinoma via the ERK1/2 signaling pathway |
| Q89736179 | Small Leucine-Rich Proteoglycans in Skin Wound Healing |
| Q41478244 | Up-regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate Cancer |
| Q47794814 | VEGF synthesis is induced by prostacyclin and TGF-β in distal lung fibroblasts from COPD patients and control subjects: Implications for pulmonary vascular remodelling |
| Q37185449 | Vascular Endothelial Growth Factor and Cluster of Differentiation 34 for Assessment of Perioperative Bleeding Risk in Gastric Cancer Patients |
Search more.